Insider Selling: Astera Labs (NASDAQ:ALAB) General Counsel Sells 14,076 Shares of Stock

by · The Cerbat Gem

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) General Counsel Philip Mazzara sold 14,076 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $231.78, for a total value of $3,262,535.28. Following the sale, the general counsel owned 104,139 shares of the company’s stock, valued at approximately $24,137,337.42. This represents a 11.91% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Philip Mazzara also recently made the following trade(s):

  • On Wednesday, April 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00.
  • On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00.

Astera Labs Stock Performance

Shares of NASDAQ ALAB traded up $43.22 during midday trading on Wednesday, hitting $287.48. 10,253,769 shares of the stock traded hands, compared to its average volume of 5,914,570. The company has a market cap of $49.28 billion, a PE ratio of 194.24, a P/E/G ratio of 3.23 and a beta of 3.35. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $287.70. The business has a 50 day moving average price of $163.12 and a two-hundred day moving average price of $157.97.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s quarterly revenue was up 93.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Assetmark Inc. boosted its position in Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Reflection Asset Management purchased a new position in Astera Labs in the fourth quarter worth $25,000. Smartleaf Asset Management LLC boosted its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank boosted its position in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after purchasing an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC purchased a new position in Astera Labs in the fourth quarter worth $33,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. TD Cowen lifted their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 target price on the stock. Citigroup lifted their target price on Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Morgan Stanley lifted their target price on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Finally, Stifel Nicolaus lifted their target price on Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Fifteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $233.75.

Get Our Latest Research Report on Astera Labs

About Astera Labs

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories